Herbst Kinsky has advised Salzburg-based dietary supplement manufacturer Biogena on a public offering for crowd-investors via the Rockets Investments platform with a total amount of up to EUR 3 million.
Gessel Advises Bioceltix on Non-Brokered Public Offering
Gessel has advised Bioceltix on a non-brokered public offering of shares carried out under an accelerated book-building procedure and the related private placement.
Tall Order for Kosovo's Assembly: A Buzz Interview with Visar Ramaj of RPHS Law
The healthcare industry is undergoing reform and the renewable energy sector is shifting to foreign-investment-friendly auction-based strategies, while the new Civil Code and large investment projects – including healthcare digitalization and infrastructure development – are on the books in Kosovo, according to RPHS Law Partner Visar Ramaj.
Gessel Advises Genomtec on Non-Brokered Public Offering
Gessel has advised Genomtec on a non-brokered public offering carried out under an accelerated book-building procedure and the related private placement of the company’s newly issued shares.
Binder Groesswang Advises Biome Diagnostics on Investment Round with SanusX
Binder Groesswang has advised microbiome technology R&D company Biome Diagnostics on its investment round with Uniqa Group company SanusX. Schoenherr reportedly advised the investors.
Sobczynski and Partners and MKS Partners Advise on THC Acquisition of Dental Medicenter
Sobczynski and Partners has advised Tar Heel Capital on the acquisition – on behalf of its Dentity dental chain – of a 70% stake in Warsaw's Dental Medicenter. Michaliszyn Koska Saluda advised the Dental Medicenter shareholders.
Gessel Advises Pure Biologics on PLN 12 Million Investment from ACRX Investments
Gessel has advised Wroclaw-based biopharmaceutical company Pure Biologics on receiving a PLN 12 million investment from ACRX Investments Limited.